← FDA DRUG APPROVALS

FDA ANDA · ANDA065303

CEFAZOLIN

cefazolin sodium

Sponsor: ACS DOBFAR

APPLICATION
ANDA065303
TYPE
ANDA
ORIGINAL APPROVAL
2008-10-22
LATEST ACTION
2010-11-29
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CEFAZOLIN SODIUMPrescription
CEFAZOLIN SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
CEFAZOLIN SODIUMPrescription
CEFAZOLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2010-11-29Labeling · Supplement 2AP
2008-10-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →